During a high‑profile murder trial in Connecticut, prosecutors and defense attorneys presented conflicting accounts of the care received by Lindsay Clancy, a mother accused of killing her three children in January 2023. The case has drawn attention to systemic problems in the state’s mental‑health system, especially for women suffering from postpartum psychosis.
Trial details and accusations
Clancy, 36, is charged with the murders of her children—Cora, 5; Dawson, 3; and infant Callan, 8 months—on Jan. 24, 2023. After the killings, she attempted suicide by jumping from a bedroom window. Prosecutors argued that she planned the deaths and even drove her husband from home to carry them out. The defense maintains that Clancy was experiencing postpartum psychosis, a rare psychiatric emergency that can distort reality and compel harmful actions.
Medical history and treatment timeline
According to court testimony, Clancy began seeing psychiatrist Dr. Jennifer Tufts at Aster Mental Health in September 2022, three months after Callan’s birth. Tufts diagnosed her with generalized anxiety disorder and an adjustment disorder with depressed mood, prescribing low‑dose sertraline (Zoloft). Clancy reported worsening symptoms after her dose was increased, leading Tufts to advise stopping the medication.
Over the next months, Clancy was prescribed a series of medications, including lorazepam (Ativan), buspirone, hydroxyzine, trazodone, fluoxetine (Prozac), mirtazapine (Remeron), clonazepam (Klonopin), zolpidem (Ambien), and the antipsychotic Seroquel. She also sought help from a suicide crisis hotline and attempted to obtain inpatient treatment, but was turned away.
Expert commentary on systemic failures
Dr. Veerle Bergink, director of Mount Sinai’s Women’s Mental Health Center, testified that Clancy’s case illustrates how diagnoses can be missed and treatment fragmented when multiple providers lack full access to a patient’s records. She suggested that adverse reactions to antidepressants may have signaled a condition beyond postpartum depression, requiring different medication for postpartum psychosis.
Psychologist Dr. Tracy Moran Vozar echoed these concerns, noting the broader issue of poor communication across health‑care systems for patients with serious mental‑illness who see several providers.
Implications for families and providers
The trial underscores the need for better coordination among mental‑health professionals, especially for new mothers at risk of postpartum psychosis. Families, churches, and community groups are urged to remain vigilant for warning signs—such as severe anxiety, insomnia, and intrusive thoughts—and to advocate for timely, comprehensive care.
While the jury has yet to reach a verdict, the courtroom testimony may prompt policymakers and health‑care leaders to review protocols for diagnosing and treating postpartum mental‑health conditions, aiming to prevent future tragedies.
Original reporting: NBC Connecticut — read the source article.
